Mutations in the von Hippel-Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma
- 12 April 2002
- journal article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 80 (1) , 52-60
- https://doi.org/10.1002/jso.10086
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Functions of the von Hippel–Lindau tumour suppressor proteinJournal of Internal Medicine, 1998
- Molecular genetic analysis of von Hippel–Lindau diseaseJournal of Internal Medicine, 1998
- Genotype–phenotype correlations in von hippel–lindau diseaseJournal of Internal Medicine, 1998
- Somatic mutations of von Hippel‐Lindau (VHL) tumor‐suppressor gene in european kidney cancersInternational Journal of Cancer, 1995
- Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotypeHuman Mutation, 1995
- Somatic mutations of the von Hippel — Lindau disease tumour suppressor gene in non-familial clear cell renal carcinomaHuman Molecular Genetics, 1994
- Mutations of the VHL tumour suppressor gene in renal carcinomaNature Genetics, 1994
- A PCR generated AccI RFLP in the 3′ untranslated region of the von Hippel — Lindau disease (VHL) tumour suppressor geneHuman Molecular Genetics, 1994
- Cytoplasmic regulation of mRNA function: The importance of the 3′ untranslated regionCell, 1993
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993